Defunct Company
Total Trials
7
As Lead Sponsor
As Collaborator
0
Total Enrollment
925
NCT00022243
T138067 in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer That Has Not Responded to Previous Chemotherapy
Phase: Phase 2
Role: Lead Sponsor
Start: Oct 31, 2000
Completion: Not specified
NCT00033722
Lometrexol Plus Folic Acid in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Start: Feb 28, 2002
NCT00043433
Study of T900607-Sodium in Chemotherapy Naive Patients With Hepatocellular Carcinoma.
Start: Jul 31, 2002
NCT00043446
Study of T900607-Sodium in Previously Treated Patients With Ovarian Cancer.
NCT00043459
Study of T900607-Sodium in Previously Treated Patients With Non-Hodgkin's Lymphoma.
Completion: Mar 31, 2003
NCT00048529
Study of T900607-Sodium in Subjects With Previously Treated Gastric Cancer or Adenocarcinoma of the Esophagus
Start: Sep 30, 2002
NCT00057382
T138067 Versus Doxorubicin in Chemotherapy-Naive, Unresectable, Hepatocellular Carcinoma Patients
Phase: Phase 2/3
Start: Mar 31, 2003